These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32158432)

  • 1. Development and Psychometric Evaluation of an Instrument Assessing Barriers to Growth Hormone Treatment (BAR-GHT).
    de Zwaan M; Fischer-Jacobs J; Wabitsch M; Reinehr T; Meckes-Ferber S; Crosby RD
    Front Endocrinol (Lausanne); 2020; 11():84. PubMed ID: 32158432
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessing the impact of growth hormone deficiency and treatment in adults: development of a new disease-specific measure.
    Brod M; Højbjerre L; Adalsteinsson JE; Rasmussen MH
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1204-12. PubMed ID: 24438372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parental perception of health-related quality of life in children and adolescents with short stature: literature review and introduction of the parent-reported QoLISSY instrument.
    Quitmann J; Rohenkohl A; Bullinger M; Chaplin JE; Herdman M; Sanz D; Mimoun E; Feigerlova E; DeBusk K; Power M; Wollmann H; Pleil A
    Pediatr Endocrinol Rev; 2013 Dec; 11(2):147-60. PubMed ID: 24575550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure, a patient-reported outcome measure.
    Brod M; Blum SI; Bushnell DM; Ramasamy A
    Qual Life Res; 2015 Dec; 24(12):3001-14. PubMed ID: 26068732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone treatment and health-related quality of life in children and adolescents: A national, prospective, one-year controlled study.
    Butler G; Turlejski T; Wales G; Bailey L; Wright N
    Clin Endocrinol (Oxf); 2019 Aug; 91(2):304-313. PubMed ID: 31077606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Psychometric Evaluation of the Life Interference Questionnaire for Growth Hormone Deficiency (LIQ-GHD) to Assess Growth Hormone Injection Burden in Children and Adults.
    Turner-Bowker DM; Yaworsky A; Palladino A; Lamoureux RE; Kelly M; Love E; Pleil AM; Shields A; Loftus J
    Patient; 2020 Jun; 13(3):289-306. PubMed ID: 31956960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Modular Health-Related Quality of Life Instrument for Electronic Assessment and Treatment Monitoring: Web-Based Development and Psychometric Validation of Core Thrive Items.
    Wicks P; McCaffrey S; Goodwin K; Black R; Hoole M; Heywood J
    J Med Internet Res; 2019 Jan; 21(1):e12075. PubMed ID: 30681962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric properties of the quality of life in short statured youth (QoLISSY) questionnaire within the course of growth hormone treatment.
    Bloemeke J; Silva N; Bullinger M; Witt S; Dörr HG; Quitmann J
    Health Qual Life Outcomes; 2019 Mar; 17(1):49. PubMed ID: 30885197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and preliminary validation of the Adolescent Psoriasis Quality of Life instrument: a disease-specific measure of quality of life in adolescents with psoriasis.
    Randa H; Khoury LR; Grønborg TK; Lomholt JJ; Skov L; Zachariae R
    Br J Dermatol; 2020 Jul; 183(1):96-104. PubMed ID: 31743420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
    McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
    Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary.
    Lipton RB; Gandhi P; Stokes J; Cala ML; Evans CJ; Knoble N; Gelhorn HL; Revicki D; Viswanathan HN; Dodick DW
    Headache; 2022 Jan; 62(1):89-105. PubMed ID: 34962305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Flemish version of the Quality of Life in Short Stature Youth (QoLISSY) questionnaire.
    Rohenkohl AC; De Schepper J; Vanderfaeillie J; Fricke K; Hendrickx S; Lagrou K; Bullinger M; Quitmann J;
    Acta Clin Belg; 2014 Jun; 69(3):177-82. PubMed ID: 24694268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of the Pediatric Charcot-Marie-Tooth Disease Quality of Life Outcome Measure.
    Ramchandren S; Wu TT; Finkel RS; Siskind CE; Feely SME; Burns J; Reilly MM; Estilow T; Shy ME;
    Ann Neurol; 2021 Feb; 89(2):369-379. PubMed ID: 33222249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic structured interviews in child and adolescent's psychiatry].
    Renou S; Hergueta T; Flament M; Mouren-Simeoni MC; Lecrubier Y
    Encephale; 2004; 30(2):122-34. PubMed ID: 15107714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parent experiences of diabetes care questionnaire (PEQ-DC): reliability and validity following a national survey in Norway.
    Iversen HH; Helland Y; Bjertnaes O; Skrivarhaug T
    BMC Health Serv Res; 2018 Oct; 18(1):774. PubMed ID: 30314486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a patient-reported outcome measure for psychotherapeutic interventions in people with seizures: A mixed methods study.
    Michaelis R; Meyer S; Reuber M; Schöne C
    Epilepsy Behav; 2019 Oct; 99():106464. PubMed ID: 31421518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric Validation of the Growth Hormone Deficiency-Child Treatment Burden Measure (GHD-CTB) and the Growth Hormone Deficiency-Parent Treatment Burden Measure (GHD-PTB).
    Brod M; Rasmussen MH; Alolga S; Beck JF; Bushnell DM; Lee KW; Maniatis A
    Pharmacoecon Open; 2023 Jan; 7(1):121-138. PubMed ID: 36255609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRISM, a Patient-Reported Outcome Instrument, Accurately Measures Symptom Change in Refractory Gastroesophageal Reflux Disease.
    Fuller G; Bolus R; Whitman C; Talley J; Erder MH; Joseph A; Silberg DG; Spiegel B
    Dig Dis Sci; 2017 Mar; 62(3):593-606. PubMed ID: 28116591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-Related Quality of Life Instruments for Children With Cochlear Implants: Development of Child and Parent-Proxy Measures.
    Hoffman MF; Cejas I; Quittner AL
    Ear Hear; 2019; 40(3):592-604. PubMed ID: 30059365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument.
    McCaffrey S; Black RA; Nagao M; Sepassi M; Sharma G; Thornton S; Kim YH; Braverman J
    J Med Internet Res; 2019 Jan; 21(1):e11302. PubMed ID: 30617041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.